| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9253537 | Journal of Hepatology | 2005 | 9 Pages |
Abstract
Future therapeutic local application of cell-permeable BCDase-TLM fusion proteins together with a systemic 5-FC prodrug application could result in profound antitumor activities without apparent side effects.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Annett Hillemann, Boerries Brandenburg, Ulrike Schmidt, Martin Roos, Irina Smirnow, Marie-Luise Lemken, Ulrich M. Lauer, Eberhard Hildt,